vs
Digimarc CORP(DMRC)与Sensus Healthcare, Inc.(SRTS)财务数据对比。点击上方公司名可切换其他公司
Digimarc CORP的季度营收约是Sensus Healthcare, Inc.的1.8倍($8.9M vs $4.9M),Digimarc CORP净利率更高(-47.2% vs -64.1%,领先16.9%),Digimarc CORP同比增速更快(2.9% vs -62.2%),Digimarc CORP自由现金流更多($895.0K vs $-2.4M),过去两年Digimarc CORP的营收复合增速更高(-5.3% vs -31.9%)
迪吉马克公司是一家企业软件与服务提供商,其主打产品包含带数字标识符的软件,主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯,产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
Sensus Healthcare, Inc.是一家医疗科技企业,主营无创浅表放射治疗设备的研发、生产与商业化,产品主要用于治疗非黑素瘤皮肤癌、瘢痕疙瘩及部分皮肤美容相关病症,服务全球各地的医疗机构与临床场所。
DMRC vs SRTS — 直观对比
营收规模更大
DMRC
是对方的1.8倍
$4.9M
营收增速更快
DMRC
高出65.1%
-62.2%
净利率更高
DMRC
高出16.9%
-64.1%
自由现金流更多
DMRC
多$3.3M
$-2.4M
两年增速更快
DMRC
近两年复合增速
-31.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $8.9M | $4.9M |
| 净利润 | $-4.2M | $-3.2M |
| 毛利率 | 63.5% | 38.4% |
| 营业利润率 | -48.2% | -63.8% |
| 净利率 | -47.2% | -64.1% |
| 营收同比 | 2.9% | -62.2% |
| 净利润同比 | 51.4% | -304.9% |
| 每股收益(稀释后) | $-0.18 | $-0.19 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
DMRC
SRTS
| Q4 25 | $8.9M | $4.9M | ||
| Q3 25 | $7.6M | $6.9M | ||
| Q2 25 | $8.0M | $7.3M | ||
| Q1 25 | $9.4M | $8.3M | ||
| Q4 24 | $8.7M | $13.1M | ||
| Q3 24 | $9.4M | $8.8M | ||
| Q2 24 | $10.4M | $9.2M | ||
| Q1 24 | $9.9M | $10.7M |
净利润
DMRC
SRTS
| Q4 25 | $-4.2M | $-3.2M | ||
| Q3 25 | $-8.2M | $-943.0K | ||
| Q2 25 | $-8.2M | $-1.0M | ||
| Q1 25 | $-11.7M | $-2.6M | ||
| Q4 24 | $-8.6M | $1.5M | ||
| Q3 24 | $-10.8M | $1.2M | ||
| Q2 24 | $-9.3M | $1.6M | ||
| Q1 24 | $-10.3M | $2.3M |
毛利率
DMRC
SRTS
| Q4 25 | 63.5% | 38.4% | ||
| Q3 25 | 58.3% | 39.4% | ||
| Q2 25 | 58.8% | 39.7% | ||
| Q1 25 | 65.0% | 52.2% | ||
| Q4 24 | 60.8% | 54.4% | ||
| Q3 24 | 62.4% | 59.3% | ||
| Q2 24 | 66.1% | 58.7% | ||
| Q1 24 | 62.5% | 62.5% |
营业利润率
DMRC
SRTS
| Q4 25 | -48.2% | -63.8% | ||
| Q3 25 | -109.7% | -37.3% | ||
| Q2 25 | -105.2% | -26.6% | ||
| Q1 25 | -128.9% | -31.7% | ||
| Q4 24 | -105.1% | 13.2% | ||
| Q3 24 | -120.4% | 16.9% | ||
| Q2 24 | -96.2% | 21.5% | ||
| Q1 24 | -109.2% | 27.1% |
净利率
DMRC
SRTS
| Q4 25 | -47.2% | -64.1% | ||
| Q3 25 | -106.9% | -13.7% | ||
| Q2 25 | -102.6% | -14.2% | ||
| Q1 25 | -125.2% | -30.8% | ||
| Q4 24 | -99.9% | 11.8% | ||
| Q3 24 | -113.9% | 13.7% | ||
| Q2 24 | -89.3% | 17.4% | ||
| Q1 24 | -104.0% | 21.3% |
每股收益(稀释后)
DMRC
SRTS
| Q4 25 | $-0.18 | $-0.19 | ||
| Q3 25 | $-0.38 | $-0.06 | ||
| Q2 25 | $-0.38 | $-0.06 | ||
| Q1 25 | $-0.55 | $-0.16 | ||
| Q4 24 | $-0.40 | $0.10 | ||
| Q3 24 | $-0.50 | $0.07 | ||
| Q2 24 | $-0.43 | $0.10 | ||
| Q1 24 | $-0.50 | $0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $12.9M | $22.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $40.2M | $48.1M |
| 总资产 | $53.0M | $53.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
DMRC
SRTS
| Q4 25 | $12.9M | $22.1M | ||
| Q3 25 | $12.6M | $24.5M | ||
| Q2 25 | $16.1M | $22.2M | ||
| Q1 25 | $21.6M | $19.1M | ||
| Q4 24 | $28.7M | $22.1M | ||
| Q3 24 | $33.7M | $22.6M | ||
| Q2 24 | $41.5M | $19.0M | ||
| Q1 24 | $48.9M | $14.7M |
股东权益
DMRC
SRTS
| Q4 25 | $40.2M | $48.1M | ||
| Q3 25 | $41.4M | $51.2M | ||
| Q2 25 | $46.5M | $52.1M | ||
| Q1 25 | $50.0M | $53.0M | ||
| Q4 24 | $61.4M | $55.8M | ||
| Q3 24 | $70.2M | $54.1M | ||
| Q2 24 | $77.2M | $52.9M | ||
| Q1 24 | $84.5M | $51.2M |
总资产
DMRC
SRTS
| Q4 25 | $53.0M | $53.0M | ||
| Q3 25 | $55.4M | $58.3M | ||
| Q2 25 | $60.7M | $58.9M | ||
| Q1 25 | $66.5M | $60.2M | ||
| Q4 24 | $75.8M | $62.2M | ||
| Q3 24 | $85.0M | $59.9M | ||
| Q2 24 | $93.4M | $58.2M | ||
| Q1 24 | $99.7M | $57.3M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $991.0K | $-2.2M |
| 自由现金流经营现金流 - 资本支出 | $895.0K | $-2.4M |
| 自由现金流率自由现金流/营收 | 10.0% | -47.9% |
| 资本支出强度资本支出/营收 | 1.1% | 3.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-12.3M | $332.0K |
8季度趋势,按日历期对齐
经营现金流
DMRC
SRTS
| Q4 25 | $991.0K | $-2.2M | ||
| Q3 25 | $-2.6M | $2.3M | ||
| Q2 25 | $-4.7M | $3.1M | ||
| Q1 25 | $-5.5M | $-2.7M | ||
| Q4 24 | $-4.2M | $-827.0K | ||
| Q3 24 | $-7.1M | $4.0M | ||
| Q2 24 | $-6.8M | $4.2M | ||
| Q1 24 | $-8.4M | $-8.2M |
自由现金流
DMRC
SRTS
| Q4 25 | $895.0K | $-2.4M | ||
| Q3 25 | $-2.8M | $2.3M | ||
| Q2 25 | $-4.9M | $3.1M | ||
| Q1 25 | $-5.5M | $-2.7M | ||
| Q4 24 | $-4.2M | $-1.1M | ||
| Q3 24 | $-7.2M | $3.6M | ||
| Q2 24 | $-6.9M | $4.2M | ||
| Q1 24 | $-8.5M | $-8.4M |
自由现金流率
DMRC
SRTS
| Q4 25 | 10.0% | -47.9% | ||
| Q3 25 | -36.9% | 33.3% | ||
| Q2 25 | -61.0% | 42.2% | ||
| Q1 25 | -59.1% | -32.2% | ||
| Q4 24 | -49.1% | -8.6% | ||
| Q3 24 | -75.7% | 40.9% | ||
| Q2 24 | -66.1% | 45.8% | ||
| Q1 24 | -85.8% | -79.0% |
资本支出强度
DMRC
SRTS
| Q4 25 | 1.1% | 3.2% | ||
| Q3 25 | 2.9% | 0.1% | ||
| Q2 25 | 2.5% | 0.4% | ||
| Q1 25 | 0.6% | 0.1% | ||
| Q4 24 | 0.2% | 2.3% | ||
| Q3 24 | 0.7% | 3.8% | ||
| Q2 24 | 0.3% | 0.0% | ||
| Q1 24 | 1.1% | 2.2% |
现金转化率
DMRC
SRTS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.53× | ||
| Q3 24 | — | 3.25× | ||
| Q2 24 | — | 2.62× | ||
| Q1 24 | — | -3.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
SRTS
| Products | $2.8M | 57% |
| Other | $2.1M | 43% |